Literature DB >> 21806381

Intracellular and extracellular cytokine-like functions of prothymosin α: implications for the development of immunotherapies.

Arevik Mosoian1.   

Abstract

Prothymosin α (ProTα) is a 12.5-kDa, highly acidic protein widely distributed in different cell types expressed intracellularly and extracellularly. ProTα does not contain a secretion-signal sequence and is released by a nonclassical secretory pathway with a cargo protein. New findings on the extracellular function of ProTα have yielded exciting insights into the cytokine-like functions of this host protein that stimulates type I interferon via Toll-like receptor 4. Here, we discuss the intracellular function of ProTα, how new findings of cytokine-like activities of ProTα aid our understanding of mechanisms that direct ProTα functions, and the potential application of these new insights to the development of immunotherapies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21806381     DOI: 10.4155/fmc.11.72

Source DB:  PubMed          Journal:  Future Med Chem        ISSN: 1756-8919            Impact factor:   3.808


  11 in total

1.  Prothymosin α variants isolated from CD8+ T cells and cervicovaginal fluid suppress HIV-1 replication through type I interferon induction.

Authors:  Avelino Teixeira; Benjamin Yen; Gabriele Luca Gusella; Albert G Thomas; Michael P Mullen; Judith Aberg; Xintong Chen; Yujin Hoshida; Harm van Bakel; Eric Schadt; Christopher F Basler; Adolfo García-Sastre; Arevik Mosoian
Journal:  J Infect Dis       Date:  2014-11-17       Impact factor: 5.226

2.  Extreme disorder in an ultrahigh-affinity protein complex.

Authors:  Alessandro Borgia; Madeleine B Borgia; Katrine Bugge; Vera M Kissling; Pétur O Heidarsson; Catarina B Fernandes; Andrea Sottini; Andrea Soranno; Karin J Buholzer; Daniel Nettels; Birthe B Kragelund; Robert B Best; Benjamin Schuler
Journal:  Nature       Date:  2018-02-21       Impact factor: 49.962

3.  Hexapeptide derived from prothymosin alpha attenuates cisplatin-induced acute kidney injury.

Authors:  Kenta Torigoe; Yoko Obata; Miki Torigoe; Satoru Oka; Kazuo Yamamoto; Takehiko Koji; Hiroshi Ueda; Hiroshi Mukae; Tomoya Nishino
Journal:  Clin Exp Nephrol       Date:  2020-01-07       Impact factor: 2.801

Review 4.  Targeting Hsp70: A possible therapy for cancer.

Authors:  Sanjay Kumar; James Stokes; Udai P Singh; Karyn Scissum Gunn; Arbind Acharya; Upender Manne; Manoj Mishra
Journal:  Cancer Lett       Date:  2016-02-17       Impact factor: 8.679

5.  Involvement of SNARE Protein Interaction for Non-classical Release of DAMPs/Alarmins Proteins, Prothymosin Alpha and S100A13.

Authors:  Hayato Matsunaga; Sebok Kumar Halder; Hiroshi Ueda
Journal:  Cell Mol Neurobiol       Date:  2020-08-27       Impact factor: 5.046

6.  Deletion of Nuclear Localizing Signal Attenuates Proinflammatory Activity of Prothymosin-Alpha and Enhances Its Neuroprotective Effect on Transient Ischemic Stroke.

Authors:  Liang-Chao Wang; Chao-Liang Wu; Ya-Yun Cheng; Kuen-Jer Tsai
Journal:  Mol Neurobiol       Date:  2016-01-09       Impact factor: 5.590

Review 7.  Thymosins in multiple sclerosis and its experimental models: moving from basic to clinical application.

Authors:  Martina Severa; Jing Zhang; Elena Giacomini; Fabiana Rizzo; Marilena Paola Etna; Melania Cruciani; Enrico Garaci; Michael Chopp; Eliana Marina Coccia
Journal:  Mult Scler Relat Disord       Date:  2018-10-02       Impact factor: 4.339

8.  Prothymosin α overexpression contributes to the development of pulmonary emphysema.

Authors:  Bing-Hua Su; Yau-Lin Tseng; Gia-Shing Shieh; Yi-Cheng Chen; Ya-Chieh Shiang; Pensee Wu; Kuo-Jung Li; Te-Hsin Yen; Ai-Li Shiau; Chao-Liang Wu
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

9.  Prothymosin-α Variants Elicit Anti-HIV-1 Response via TLR4 Dependent and Independent Pathways.

Authors:  G Luca Gusella; Avelino Teixeira; Judith Aberg; Vladimir N Uversky; Arevik Mosoian
Journal:  PLoS One       Date:  2016-06-16       Impact factor: 3.240

10.  Circulating miRNAs as Putative Biomarkers of Exercise Adaptation in Endurance Horses.

Authors:  Katia Cappelli; Stefano Capomaccio; Andrea Viglino; Maurizio Silvestrelli; Francesca Beccati; Livia Moscati; Elisabetta Chiaradia
Journal:  Front Physiol       Date:  2018-04-24       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.